Does Cost-Effectiveness Analysis Really Need to Abandon the Incremental Cost-Effectiveness Ratio to Embrace Net Benefit? James F. O’Mahony Editorial 15 June 2020 Pages: 777 - 779
Calculating and Interpreting ICERs and Net Benefit Mike Paulden Practical Application 11 May 2020 Pages: 785 - 807
Adherence to Discounting Guidelines: Evidence from Over 2000 Published Cost-Effectiveness Analyses Michelle Q. T. KwokMistura A. KareemJames F. O’Mahony Review Article 28 April 2020 Pages: 809 - 818
A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost Typology Lucy CunnamaGabriela B. GomezEdina Sinanovic Systematic Review Open access 04 May 2020 Pages: 819 - 837
Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States Kristina BurströmFitsum Sebsibe TeniMartin Henriksson Original Research Article Open access 20 April 2020 Pages: 839 - 856
Estimating the Value of New Antimicrobials in the Context of Antimicrobial Resistance: Development and Application of a Dynamic Disease Transmission Model Jason GordonOliver DarlingtonMark Wilcox Original Research Article Open access 06 April 2020 Pages: 857 - 869
Valuing the AD-5D Dementia Utility Instrument: An Estimation of a General Population Tariff Tracy A. ComansKim-Huong NguyenBrendan Mulhern Original Research Article 21 April 2020 Pages: 871 - 881
Real-World Evidence on the Societal Economic Relapse Costs in Patients with Multiple Sclerosis Nils-Henning NessDirk SchrieferTjalf Ziemssen Original Research Article Open access 04 May 2020 Pages: 883 - 892
Comment on “Replacing the NCCN’s Blocks with Wheels: How Should Consideration of Societal Spending be Incorporated into Oncology Practice?” Wui-Jin KohRobert W. Carlson Letter to the Editor Open access 26 June 2020 Pages: 893 - 894
Response to Comment on “Replacing the NCCN’s Blocks with Wheels: How Should Consideration of Societal Spending be Incorporated into Oncology Practice?” Audrey TranVinay Prasad Letter to the Editor 26 June 2020 Pages: 895 - 896
Correction to: Real-World Evidence on the Patterns of Increased Societal Economic Relapse Costs in Patients with Multiple Sclerosis Nils-Henning NessDirk SchrieferTjalf Ziemssen Correction Open access 13 May 2020 Pages: 897 - 897
Correction to: A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost Typology Lucy CunnamaGabriela B. GomezEdina Sinanovic Correction Open access 27 May 2020 Pages: 899 - 900